closeicon
World

Top Palestinian peace negotiator Saeb Erekat dies after contracting Covid-19

Tributes paid to man who ‘ devoted his life to … end the Israeli-Palestinian conflict’

articlemain

Chief Palestinian negotiator Saeb Erekat died on Tuesday at 65 after contracting Covid-19 last month, the Associated Press reported. 

The senior official was treated in intensive care at Hadassah Medical Centre in Jerusalem where he was put on a ventilator and heavily sedated. 

In a statement last month, the hospital described Mr Erekat as a “complex patient” and said he was “a great challenge in terms of his corona treatment."

He was “a lung transplantee with a depressed immune system” and also had a bacterial infection, Hadassah said at the time.

A staunch advocate of a two-state solution, he was for several decades the Palestinians’ chief negotiator in peace talks with Israel. 

He helped negotiate the historic Oslo Accords in 1993, which led to the creation of the Palestinian Authority. 

Foreign secretary Dominic Raab praised the "champion of dialogue and Palestinian rights" and said his thoughts were "with his family and the Palestinian people at this difficult time."

In a statement, the UK Jewish group Yachad paid tribute to the  “Palestinian patriot who devoted his life to advance Palestinian independence, end the Israeli-Palestinian conflict and achieve peace through diplomacy.”

Former White House Middle East envoy Jason D. Greenblatt said that while he and Mr Erekat were "worlds apart" in their views on the conflict, "he tried hard to represent his people."

He offered his "deep condolences" to the family and wished them "much comfort /strength during this difficult time."

Mr Erekat is survived by his wife, four children and eight grandchildren, according to the AP.

Share via

Want more from the JC?

To continue reading, we just need a few details...

Want more from
the JC?

To continue reading, we just
need a few details...

Get the best news and views from across the Jewish world Get subscriber-only offers from our partners Subscribe to get access to our e-paper and archive